Antitoxin Treatment of Inhalation Anthrax A Systematic Review
Huang, E., Pillai, S., Bower, W., et al. (2014). Antitoxin Treatment of Inhalation Anthrax: A Systematic Review. Health Security. 13(6):365-377.
The authors completed a systematic review (albeit with limited data) of human and animal studies on antitoxin treatment of inhalational anthrax. They found that early treatment with antimicrobial monotherapy or antimicrobial-antitoxin therapy were both associated with survival in animal studies. When treatment was delayed in animal studies, data suggested improved survivability for antimicrobial-antitoxin therapy compared to antimicrobial monotherapy. During large-scale anthrax incidents in which demand for antitoxin may exceed supply, the authors suggest that antitoxins be reserved for those who present with severe illness at onset but have a reasonable chance of survival and those who have not shown a clinical benefit from antimicrobials alone. The authors discussed numerous limitations to their study and emphasized the need for additional research.
Login to rate, favorite, and comments on the article
You must Login to add a comment
- This item doesn't have any comments